Sildenafil Citrate Powder, For Suspension
Product Images NDC 67877-648

17 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 67877-648). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Sildenafil 1st P)

Structure (Sildenafil 1st P)
Chemical structure of Sildenafil Citrate showing its molecular framework including heterocyclic rings, sulfonamide group, and citrate moiety.*
FDA Label Image

Sildenafil-fig7-a (Sildenafil Fig7 A)

Sildenafil-fig7-a (Sildenafil Fig7 A)
A chart showing fold change and 90% confidence intervals in drug exposure (AUC and Cmax) for various drugs when coadministered with Sildenafil Citrate. It includes drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, with corresponding recommendations on dose adjustments.*
FDA Label Image

Sildenafil-fig8-a (Sildenafil Fig8 A)

Sildenafil-fig8-a (Sildenafil Fig8 A)
A chart showing fold changes with 90% confidence intervals for various interacting drugs relative to the interacting drug alone, including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin (three dosages), Ethinyloestradiol, Levonorgestrel, Phenprocoumone, Ritonavir, Saquinavir, and Tolbutamide. The chart indicates fold change along the x-axis from 0.5 to 2, with recommendations such as no dose adjustment or coadministration not recommended for certain drugs.*
FDA Label Image

Sildenafil-fig9 (Sildenafil Fig9)

Sildenafil-fig9 (Sildenafil Fig9)
A line graph showing changes from baseline in a measured variable over weeks 4, 8, and 12 of a study. The x-axis is labeled 'Week of Study,' and the y-axis represents 'Change from Baseline (hectares).' Four different groups are compared: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID, as indicated in the legend. Error bars show variability in measurements at each time point.*
FDA Label Image

Sildenafil-fig10 (Sildenafil Fig10)

Sildenafil-fig10 (Sildenafil Fig10)
A forest plot chart comparing the placebo-corrected change in 6-minute walk distance for Sildenafil 20 mg TID versus placebo across various patient subgroups. Subgroups include baseline walk distance, etiology of pulmonary arterial hypertension, functional capacity class, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance index. The chart shows effect sizes with confidence intervals for each subgroup.*
FDA Label Image

Sildenafil-fig11 (Sildenafil Fig11)

Sildenafil-fig11 (Sildenafil Fig11)
A survival curve graph showing the percentage without a clinically worsening event over time (days from randomization) comparing Sildenafil and Placebo groups. The y-axis represents the percentage without worsening events, while the x-axis represents days from randomization up to 112 days. The Sildenafil group maintains a higher percentage without events than the Placebo group throughout the period.*
FDA Label Image

Sildenafil-a1fig (Sildenafil A1fig)

Sildenafil-a1fig (Sildenafil A1fig)
An illustration showing components of a Sildenafil Citrate 10 mg/mL powder for suspension oral dosage form, including a bottle of oral suspension, bottle adaptor, cap, and oral dosing syringe labeled with tip, barrel, and plunger. The bottle is labeled by Ascend Laboratories, LLC.*
FDA Label Image

Sildenafil-b2fig (Sildenafil B2fig)

Sildenafil-b2fig (Sildenafil B2fig)
An instructional illustration showing a hand holding a bottle of Sildenafil oral suspension 10 mg/mL. Arrows indicate shaking the bottle up and down and side to side. Next to it is a stopwatch image labeled Figure B, suggesting timing related to the medication use.*
FDA Label Image

Sildenafil-fig-c (Sildenafil Fig C)

Sildenafil-fig-c (Sildenafil Fig C)
An instructional image demonstrating how to open a bottle of Sildenafil Citrate oral suspension. It shows a hand gripping the child-resistant cap, indicating to press down and turn the cap counterclockwise to open.*
FDA Label Image

Sildenafil-fig-d (Sildenafil Fig D)

Sildenafil-fig-d (Sildenafil Fig D)
Illustration showing the use of a dosing syringe with Sildenafil Citrate oral suspension 10 mg/mL. The first image on the left demonstrates pushing down the syringe plunger, while the second image shows the syringe being inserted into the bottle neck of the Sildenafil Citrate suspension bottle for oral administration.*
FDA Label Image

Sildenafil-fig-e (Sildenafil Fig E)

Sildenafil-fig-e (Sildenafil Fig E)
An instructional photograph showing a person holding a bottle of Sildenafil Citrate powder for suspension 10 mg/mL and drawing the liquid into an oral syringe, demonstrating preparation of the oral suspension dose. The label on the bottle displays the product name and strength.*
FDA Label Image

Sildenafil-fig-f (Sildenafil Fig F)

Sildenafil-fig-f (Sildenafil Fig F)
An instructional illustration showing a hand holding a bottle of Sildenafil Citrate 10 mg/mL oral powder for suspension with a syringe inserted into the bottle, demonstrating how to properly withdraw the liquid medication upward using the syringe.*
FDA Label Image

Sildenafil-fig-g (Sildenafil Fig G)

Sildenafil-fig-g (Sildenafil Fig G)
Illustration showing oral administration of medication using a syringe for an adult and a child. The left side depicts an adult receiving the dose by placing the syringe into the mouth, while the right side shows a child sitting in a chair with the syringe inserted into the mouth, indicating appropriate technique for each age group.*
FDA Label Image

Sildenafil-h1fig (Sildenafil H1fig)

Sildenafil-h1fig (Sildenafil H1fig)
Illustration showing a person holding a bottle of Sildenafil Citrate oral suspension (10 mg/mL) with one hand while the other hand grasps the cap, demonstrating how to twist the cap to open the bottle. The image visually instructs the user on opening the bottle of this powder for suspension formulation.*
FDA Label Image

Sildenafil-fig-i (Sildenafil Fig I)

Sildenafil-fig-i (Sildenafil Fig I)
Illustration showing hands holding a syringe under running water, demonstrating a process of rinsing or cleaning the syringe. The image appears instructional and is related to proper handling or preparation techniques for the product.*
FDA Label Image

Sildenafil-cont-a (Sildenafil Cont A)

Sildenafil-cont-a (Sildenafil Cont A)
Label for Sildenafil Citrate 10 mg/mL oral suspension powder, manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The label includes storage instructions before and after reconstitution, dosage volume of 112 mL after reconstitution, and instructions to shake well before use. It specifies the product is Rx only and grape flavored.*
FDA Label Image

Sildenafil-cart-a (Sildenafil Cart A)

Sildenafil-cart-a (Sildenafil Cart A)
Packaging label for Sildenafil for Oral Suspension 10 mg/mL powder, for suspension, grape flavored. The label indicates 112 mL following reconstitution, for oral use only, and instructs to shake well before each use. Manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.